• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转染色素上皮衍生因子(PEDF)的色素上皮细胞移植可抑制兔角膜新生血管形成。

Transplantation of PEDF-transfected pigment epithelial cells inhibits corneal neovascularization in a rabbit model.

作者信息

Kuerten David, Johnen Sandra, Harmening Nina, Souteyrand George, Walter Peter, Thumann Gabriele

机构信息

Department of Ophthalmology, RWTH Aachen University, Pauwelsstraße 30, 52074, Aachen, Germany.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2015 Jul;253(7):1061-9. doi: 10.1007/s00417-015-2954-x. Epub 2015 Feb 18.

DOI:10.1007/s00417-015-2954-x
PMID:25690979
Abstract

BACKGROUND

The purpose of this study was to investigate the effect of recombinant pigment epithelium-derived factor (rPEDF), secreted by ARPE-19 cells transfected with the human PEDF gene and transplanted subconjunctivally in normal and in rabbits in which corneal neovascularization was elicited by a chemical burn.

METHODS

Twenty grey Chinchilla Bastard rabbits were randomly assigned to four groups; neovascularization was induced in groups A, B, and C by alkali cauterization. Seven days later, group A received no cell implantation, non-transfected ARPE-19 cells were implanted subconjunctivally in group B, and PEDF-transfected ARPE-19 cells were implanted subconjunctivally in groups C and D (non-cauterized). In-vivo rPEDF secretion was analyzed by immunoblotting, and ELISA of extracts of conjunctival tissue samples taken at different time points. Digital photographs acquired on days 7, 14, and 21 after cauterization were evaluated for lead vessel length, vascular invasion area, and overall neovascularization rate.

RESULTS

At days 14 and 21 after cauterization, significant differences were observed between groups A, B, and C in lead vessel length (day 21: 5.91 ± 0.45, 5.11 ± 1.22, 3.79 ± 0.59 mm, repectively), vascular invasion area (day 21: 35.5 ± 8.65, 34.86 ± 4.92, 19.2 ± 5.03 mm(2) respectively), and rate of corneal neovascularization. Compared to controls, neovascularization was reduced by 37.5 % on day 14 and 47 % on day 21. Analysis of conjunctival tissue extracts showed that rPEDF was secreted by the transplanted PEDF-transfected cells.

CONCLUSION

Subconjunctivally transplanted, PEDF-transfected ARPE-19 cells secrete rPEDF, which inhibits the corneal neovascularization elicited by alkali cauterization.

摘要

背景

本研究旨在探讨转染人色素上皮衍生因子(PEDF)基因的ARPE - 19细胞分泌的重组色素上皮衍生因子(rPEDF),结膜下移植到正常兔以及化学烧伤诱导角膜新生血管形成的兔体内后的作用。

方法

将20只灰色青紫蓝杂种兔随机分为四组;A、B、C组通过碱烧伤诱导新生血管形成。7天后,A组不进行细胞植入,B组结膜下植入未转染的ARPE - 19细胞,C组和D组(未烧伤组)结膜下植入转染PEDF的ARPE - 19细胞。通过免疫印迹法分析体内rPEDF分泌情况,并对不同时间点采集的结膜组织样本提取物进行酶联免疫吸附测定(ELISA)。对烧伤后第7、14和21天拍摄的数码照片评估引导血管长度、血管侵入面积和总体新生血管形成率。

结果

在烧伤后第14天和21天,A、B、C组在引导血管长度(第21天:分别为5.91±0.45、5.11±1.22、3.79±0.59 mm)、血管侵入面积(第21天:分别为35.5±8.65、34.86±4.92、19.2±5.03 mm²)和角膜新生血管形成率方面存在显著差异。与对照组相比,第14天新生血管形成减少37.5%,第21天减少47%。结膜组织提取物分析表明,转染PEDF的移植细胞分泌rPEDF。

结论

结膜下移植的转染PEDF的ARPE - 19细胞分泌rPEDF,可抑制碱烧伤诱导的角膜新生血管形成。

相似文献

1
Transplantation of PEDF-transfected pigment epithelial cells inhibits corneal neovascularization in a rabbit model.转染色素上皮衍生因子(PEDF)的色素上皮细胞移植可抑制兔角膜新生血管形成。
Graefes Arch Clin Exp Ophthalmol. 2015 Jul;253(7):1061-9. doi: 10.1007/s00417-015-2954-x. Epub 2015 Feb 18.
2
Inhibition of corneal neovascularization with plasmid pigment epithelium-derived factor (p-PEDF) delivered by synthetic amphiphile INTeraction-18 (SAINT-18) vector in an experimental model of rat corneal angiogenesis.实验性大鼠角膜血管生成模型中,通过合成两亲分子 INTeraction-18(SAINT-18)载体递送质粒色素上皮衍生因子(p-PEDF)抑制角膜新生血管形成。
Exp Eye Res. 2009 Nov;89(5):678-85. doi: 10.1016/j.exer.2009.06.021. Epub 2009 Jul 9.
3
Endogenic regulation of proliferation and zinc transporters by pigment epithelial cells nonvirally transfected with PEDF.色素上皮细胞非病毒转染 PEDF 对内源性增殖和锌转运体的调节。
Invest Ophthalmol Vis Sci. 2011 Jul 23;52(8):5400-7. doi: 10.1167/iovs.10-6178.
4
Antiangiogenic and Neurogenic Activities of Sleeping Beauty-Mediated PEDF-Transfected RPE Cells In Vitro and In Vivo.睡美人介导的PEDF转染视网膜色素上皮细胞的抗血管生成和神经生成活性:体内外研究
Biomed Res Int. 2015;2015:863845. doi: 10.1155/2015/863845. Epub 2015 Dec 1.
5
Inhibition of corneal neovascularization with the combination of bevacizumab and plasmid pigment epithelium-derived factor-synthetic amphiphile INTeraction-18 (p-PEDF-SAINT-18) vector in a rat corneal experimental angiogenesis model.在大鼠角膜实验性血管生成模型中,贝伐单抗与质粒色素上皮衍生因子-合成两亲分子相互作用-18(p-PEDF-SAINT-18)载体联合使用对角膜新生血管形成的抑制作用。
Int J Mol Sci. 2013 Apr 16;14(4):8291-305. doi: 10.3390/ijms14048291.
6
A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization.一种靶向血管内皮生长因子-A 的 siRNA 抑制实验性角膜新生血管形成。
Curr Eye Res. 2010 May;35(5):375-84. doi: 10.3109/02713681003597230.
7
Nornicotine and Nicotine Induced Neovascularization via Increased VEGF/PEDF Ratio.去甲烟碱和烟碱通过增加VEGF/PEDF比值诱导新生血管形成。
Ophthalmic Res. 2015;55(1):1-9. doi: 10.1159/000440847. Epub 2015 Nov 5.
8
Tissue-targeted and localized AAV5-DCN and AAV5-PEDF combination gene therapy abrogates corneal fibrosis and concurrent neovascularization in rabbit eyes in vivo.组织靶向和局部 AAV5-DCN 和 AAV5-PEDF 联合基因治疗在兔眼体内消除角膜纤维化和并发新生血管形成。
Ocul Surf. 2024 Apr;32:13-25. doi: 10.1016/j.jtos.2024.01.001. Epub 2024 Jan 6.
9
Inhibition of chemical cautery-induced corneal neovascularization by topical pigment epithelium-derived factor eyedrops.局部应用色素上皮衍生因子滴眼剂抑制化学烧灼诱导的角膜新生血管。
Cornea. 2010 Sep;29(9):1055-61. doi: 10.1097/ICO.0b013e3181cc7987.
10
Sleeping Beauty transposon-mediated transfection of retinal and iris pigment epithelial cells.睡美人转座子介导的视网膜和虹膜色素上皮细胞转染。
Invest Ophthalmol Vis Sci. 2012 Jul 18;53(8):4787-96. doi: 10.1167/iovs.12-9951.

引用本文的文献

1
Enhanced Biosafety of the Transposon System by Using mRNA as Source of Transposase to Efficiently and Stably Transfect Retinal Pigment Epithelial Cells.利用 mRNA 作为转座酶的来源增强转座子系统的生物安全性,以高效稳定地转染视网膜色素上皮细胞。
Biomolecules. 2023 Apr 7;13(4):658. doi: 10.3390/biom13040658.
2
Molecular and Functional Characterization of BDNF-Overexpressing Human Retinal Pigment Epithelial Cells Established by Transposon-Mediated Gene Transfer.转座子介导基因转移建立的 BDNF 过表达人视网膜色素上皮细胞的分子和功能特征。
Int J Mol Sci. 2022 Oct 26;23(21):12982. doi: 10.3390/ijms232112982.
3
Deliver protein across bio-barriers via hexa-histidine metal assemblies for therapy: a case in corneal neovascularization model.

本文引用的文献

1
Inhibition of corneal neovascularization with the combination of bevacizumab and plasmid pigment epithelium-derived factor-synthetic amphiphile INTeraction-18 (p-PEDF-SAINT-18) vector in a rat corneal experimental angiogenesis model.在大鼠角膜实验性血管生成模型中,贝伐单抗与质粒色素上皮衍生因子-合成两亲分子相互作用-18(p-PEDF-SAINT-18)载体联合使用对角膜新生血管形成的抑制作用。
Int J Mol Sci. 2013 Apr 16;14(4):8291-305. doi: 10.3390/ijms14048291.
2
Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial.结膜下注射贝伐单抗诱导角膜新生血管消退:一项初步随机安慰剂对照双盲试验。
Br J Ophthalmol. 2013 Jan;97(1):28-32. doi: 10.1136/bjophthalmol-2012-302137. Epub 2012 Oct 20.
3
通过六组氨酸金属组装体跨越生物屏障递送蛋白质用于治疗:以角膜新生血管模型为例。
Mater Today Bio. 2021 Oct 1;12:100143. doi: 10.1016/j.mtbio.2021.100143. eCollection 2021 Sep.
4
Current and emerging therapies for corneal neovascularization.角膜新生血管的当前和新兴治疗方法。
Ocul Surf. 2018 Oct;16(4):398-414. doi: 10.1016/j.jtos.2018.06.004. Epub 2018 Jun 20.
5
The Antibiotic-free pFAR4 Vector Paired with the Sleeping Beauty Transposon System Mediates Efficient Transgene Delivery in Human Cells.无抗生素的pFAR4载体与睡美人转座子系统配对可介导在人类细胞中高效传递转基因。
Mol Ther Nucleic Acids. 2018 Jun 1;11:57-67. doi: 10.1016/j.omtn.2017.12.017. Epub 2017 Dec 30.
6
Engineering of PEDF-Expressing Primary Pigment Epithelial Cells by the SB Transposon System Delivered by pFAR4 Plasmids.通过pFAR4质粒递送的SB转座子系统构建表达色素上皮衍生因子(PEDF)的原代色素上皮细胞
Mol Ther Nucleic Acids. 2017 Mar 17;6:302-314. doi: 10.1016/j.omtn.2017.02.002. Epub 2017 Feb 10.
7
Molecular underpinnings of corneal angiogenesis: advances over the past decade.角膜血管生成的分子基础:过去十年的进展
Int J Ophthalmol. 2016 May 18;9(5):768-79. doi: 10.18240/ijo.2016.05.24. eCollection 2016.
Sleeping Beauty transposon-mediated transfection of retinal and iris pigment epithelial cells.睡美人转座子介导的视网膜和虹膜色素上皮细胞转染。
Invest Ophthalmol Vis Sci. 2012 Jul 18;53(8):4787-96. doi: 10.1167/iovs.12-9951.
4
Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization.聚乙二醇修饰的色素上皮衍生因子:治疗视网膜新生血管的新前景。
J Pharmacol Exp Ther. 2012 Jul;342(1):131-9. doi: 10.1124/jpet.112.192575. Epub 2012 Apr 10.
5
Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable.关于抗血管生成治疗在新生血管相关性角膜疾病管理中的适应证的专家共识声明:专家圆桌会议的结果。
Br J Ophthalmol. 2012 Jan;96(1):3-9. doi: 10.1136/bjo.2011.204701. Epub 2011 Jun 28.
6
[Subconjunctival bevacizumab for corneal neovascularization].结膜下注射贝伐单抗治疗角膜新生血管
J Fr Ophtalmol. 2010 Nov;33(9):630-6. doi: 10.1016/j.jfo.2010.07.007. Epub 2010 Oct 29.
7
Subconjunctival injection of bevacizumab in the treatment of corneal neovascularization associated with lipid deposition.玻璃体内注射贝伐单抗治疗伴有脂质沉积的角膜新生血管。
Cornea. 2011 Jan;30(1):60-6. doi: 10.1097/ICO.0b013e3181e458c5.
8
The effect of bevacizumab on corneal neovascularization in rabbits.贝伐单抗对兔角膜新生血管形成的影响。
Korean J Ophthalmol. 2010 Aug;24(4):230-6. doi: 10.3341/kjo.2010.24.4.230. Epub 2010 Aug 3.
9
Severe corneal changes following intravitreal injection of bevacizumab.玻璃体内注射贝伐单抗后严重的角膜改变。
Ocul Immunol Inflamm. 2010 Aug;18(4):268-74. doi: 10.3109/09273948.2010.490630.
10
Inhibition of corneal neovascularization by topical bevacizumab (Anti-VEGF) and Sunitinib (Anti-VEGF and Anti-PDGF) in an animal model.在动物模型中,局部应用贝伐单抗(抗 VEGF)和舒尼替尼(抗 VEGF 和抗 PDGF)抑制角膜新生血管形成。
Am J Ophthalmol. 2010 Oct;150(4):519-528.e1. doi: 10.1016/j.ajo.2010.04.024. Epub 2010 Jun 29.